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Introduction
The incidence of multivessel disease (MVD) in patients with acute 
myocardial infarction (AMI) is reported to be 40-50%. The morbid-
ity and mortality are higher in patients with MVD versus single ves-
sel disease (SVD).
1-6) Chronic total occlusion (CTO) is commonly fo-
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und on diagnostic angiography in patients with coronary artery dise-
ase.
7)8) Recent studies have shown that the effects of MVD on long 
term mortality are due to the presence of CTO in a noninfarct-re-
lated artery.
9)10) These findings suggest that CTO lesion in a non-in-
farct related artery was a modifiable risk factor for mortality after 
AMI. However, successfully opened CTO lesions were not included 
in these studies. Therefore, we investigated the impact of MVD with 
CTO lesion on 12-month mortality in patients with AMI, including 
successfully opened lesions.
Subjects and Methods
Patients
Between November 2005 and December 2008, 1094 patients with 
a diagnosis of AMI underwent coronary angiogram at Kyungpook 
National University Hospital in Daegu, Korea. Of these patients, 21 
patients who had undergone coronary bypass surgery within 30 
days after index hospitalization were excluded from the study. Also 96  Impact of Chronic Total Occlusion
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excluded were 65 patients who did not provide 12-month clinical fol-
low-up data. Therefore, data on 1008 patients were retrospectively 
analyzed in this study. 
Definition
Acute myocardial infarction was defined by the World Health Or-
ganization criteria incorporating clincial features, elevated bioche-
mistry markers and electrocardiographic findings.
11) ST-segment 
elevation myocardial infarction (STEMI) was defined as a new ST ele-
vation in ≥2 contiguous leads, measuring >0.2 mV in leads V1 to V3, 
or 0.1 mV in all other leads. Killip class was defined at admission. 
Left ventricular ejection fraction (LVEF) was measured by 2-dimen-
sional echocardiogram. MVD was defined as visually assessed ≥70% 
diameter stenosis of at least one of the non-infarct-related arteries. 
CTO was defined as total occlusion of an estimated duration of >3 
months. Identical angiographic criteria with regard to vessel size 
(≥2.5 mm) and coronary artery lesion were used to qualify for the 
presence of MVD and/or a CTO. The duration of the occlusion was 
estimated from clinical events such as myocardial infarction and 
sudden onset or worsening of the symptoms or was proven by pre-
vious angiography. In patients without a history of angina and with 
a definite identification of the culprit vessel, associated total oc-
clusion of a non-culprit vessel was considered a chronic occlusion if 
there was angiographic evidence of filling of the vessel through col-
laterals. If the duration of the occlusion was uncertain and the in-
vestigators had no clear reason to estimate the CTO <3 months, the 
patient was included. 
Treatment
Primary percutaneous coronary intervention (PCI), thrombolysis, 
or conservative treatment was used as the initial treatment strate-
gy for patients with STEMI at the discretion of the attending doctor. 
For patients with non-STEMI (NSTEMI), the initial treatment strate-
gy was early invasive PCI or conservative treatment according to 
the American College of Cardiology and the American Heart Asso-
ciation guidelines for the management of patients with acute cor-
onary syndrome. Prescription of evidence-based medications was 
encouraged whenever clinically indicated. 
Primary outcomes
The primary outcome for the present analysis was all-cause 12- 
month mortality. During the follow-up period, follow-up data were 
obtained by reviewing medical records and by telephone interview 
with patients.
Statistical analysis
Data are expressed as mean±SD for continuous variables and 
percentages for categorical variables. All comparisons between 
baseline variables were assessed with the Student’s t-test for con-
tinuous variables and the Pearson’s Chi-square test for categorical 
variables. Cumulative survival curves were constructed according 
to the Kaplan-Meier method, and significance of differences be-
tween the curves were calculated by log-rank test. Cox proportion-
al-hazards model was used to determine independent predictors 
of all-cause death. Univariate predictors of 12-month mortality were 
included in the multivariate cox proportional analysis. Age (≥65 
years) was dichotomised for the multivariate analysis. For all analy-
ses, a two-sided p<0.05 was considered statistically significant. St-
atistical analysis was performed using Statistical Package for the 
Social Sciences (SPSS) version 12.0 (SPSS Inc., Chicago, IL, USA). 
Results
The mean age was 63±11 years, and 698 patients (69%) were men. 
Among all patients, 432 patients (43%) had MVD. The baseline ch-
aracteristics of the patients are listed in Table 1. Patients with MVD 
were older than patients with SVD (64.7±10.6 years vs. 61.5±11.8 
years, p<0.001). A history of hypertension or diabetes was more com-
mon in patients with MVD than in those with SVD (54.0% vs. 37.5%, 
p<0.001; 36.4% vs. 22.9%, p<0.001). Previous myocardial infarction 
(MI) was also more frequent in patients with MVD (9.3% vs. 3.8%, 
p<0.001). However, the prevalence of smoking was lower in patients 
with MVD than in those with SVD (60.9% vs. 68.0%, p=0.022). STEMI 
was more prevalent in patients with SVD (60.5% vs. 41.0%, p<0.001). 
The LVEF was lower (50.8±11.0% vs. 53.2±9.8%, p=0.001) and Killip 
class III or IV was more common in patients with MVD than in those 
with SVD (20.6% vs.12.2%, p=0.001). The left anterior descending 
Table 1. Characteristics of 1008 patients with and without multivessel cor-
onary disease
Variable
Coronary arteries narrowed
p
1 (n=576) >1 (n=432)
Age (years) 61.5±11.8 64.7±10.6 <0.001
Men (%) 401 (70) 297 (68.8) 0.675
Hypertension (%) 215 (37.5) 230 (54.0) <0.001
Smoker (%) 383 (68.0) 248 (60.9) 0.022
Diabetes mellitus (%) 131 (22.9) 155 (36.4) <0.001
Hyperlipidemia (%) 169 (32.5) 114 (30.1) 0.440
Previous MI (%) 22 (3.8) 40 (9.3) <0.001
Ejection fraction 53.2±9.8 50.8±11.0 0.001
Killip class ≥III (%) 66 (12.2) 82 (20.6) 0.001
STEMI (%) 347 (60.5) 177 (41.0) <0.001
MI related to LAD (%) 272 (47.8) 147 (35.5) <0.001
MI: myocardial infarction, STEMI: ST-segment elevation MI, LAD: left ante-
rior descending artery97 Ju Hwan Lee, et al.
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artery was the most frequent infarct-related lesion in SVD (47.8%), 
compared to the right coronary artery in MVD (35.6%). There was no 
significant difference in gender or the prevalence of hyperlipidemia 
between the two groups. Twelve-month clinical follow-up outcomes 
are listed in Table 2. During the 12-month follow-up, 78 patients 
died (7.7%). The overall mortality in patients with MVD was higher 
than that in patients with SVD (10.2% vs. 5.9%, p=0.012). The car-
diac mortality was also higher in patients with MVD (9.5% vs. 4.7%, 
p=0.003). Kaplan-Meier survival estimates for 12-month mortality 
in patients with MVD and SVD are shown in Fig. 1.
Among the 1008 patients, 88 (8.7%) patients had CTO lesion. CTO 
PCI was attempted in 60 (68%) patients. Successful opening was 
obtained in 66% of the attempted cases. Clinical characteristics 
are presented in Table 3. Patients with CTO lesion were older than 
patients without CTO lesion (65.7±10.2 years vs. 62.6±11.5 years, 
p=0.015). A history of diabetes (41.9% vs. 27.4%, p=0.005) or previ-
ous MI (21.6% vs. 4.7%, p<0.001) was more common in patients with 
CTO lesion than in those without that lesion. The frequency of STEMI 
was lower in patients with CTO lesion (29.5% vs. 54.2%, p<0.001). 
The LVEF was also lower in patients with CTO lesion (49.1±10.3% vs. 
52.5±10.3%, p=0.006). Killip class III or IV was also more common 
in patients with CTO lesion (27.4% vs. 14.6%, p=0.002). There was 
no significant difference in gender or the prevalence of hyperten-
sion, smoking and hyperlipidemia between the two groups. The 
frequency of left anterior descending artery as the infarct-related 
artery was also similar between the two groups. 
Twelve-month overall mortality was not significantly higher in 
patients with CTO lesion than in patients without that lesion (12.5% 
vs. 7.3%, p=0.080). However, cardiac mortality was higher in pa-
tients with CTO lesion (12.5% vs. 6.2%, p=0.024). Kaplan-Meier sur-
vival estimates for 12- month mortality in patients with or without 
CTO are shown in Fig. 2.
To examine the independent prognostic value of CTO, multivari-
ate analysis was performed (Table 4). Independent predictors of 
one-year overall mortality were: age older than 65 years {hazard ra-
tio (HR) 2.41, 95% confidence interval (CI): 1.43 to 4.08}, Killip class 
≥III (HR 3.59, 95% CI: 2.24 to 5.77), STEMI (HR 2.45, 95% CI: 1.49 
to 4.05) and MVD (HR 1.76, 95% CI: 1.07 to 2.89). Independent pre-
dictors of one-year cardiac death were age older than 65 years (HR 
2.50, 95% CI: 1.42 to 4.39), Killip class ≥III (HR 3.55, 95% CI: 2.14 
to 5.90), STEMI (HR 3.16, 95% CI: 1.81 to 5.53) and MVD (HR 2.11, 
95% CI: 1.23 to 3.61) (Table 4). The presence of CTO was not a signifi-
Table 2. Twelve-month clinical outcome
MVD
p
CTO
p
CTO PCI
p No
(n=576)
Yes
(n=432) 
No
(n=920)
Yes
(n=88)
Group A
(n=40)
Group B
(n=48)
Overall mortality (%) 34 (5.9) 44 (10.2) 0.012 67 (7.3) 11 (12.5) 0.080 0 11 (22.9) 0.001
Cardiac mortality (%) 27 (4.7) 41 (9.5) 0.003 57 (6.2) 11 (12.5) 0.024 0 11 (22.9) 0.001
MVD: multivessel disease, CTO: chronic total occlusion, PCI: percutaneous coronary intervention, Group A: CTO PCI success, Group B: CTO PCI failure (n=12)/
non-attempt (n=36)
Fig. 1. Twelve-month the overall mortality.
40
30
20
10
0
Follow up (days)
M
o
r
t
a
l
i
t
y
 
(
%
)
0                  60               120              180               240              300              360
Log rank: 6.389, p=0.011
Table 3. Characteristics of 1008 patients with and without a chronic total 
occlusion
Variable
Chronic total occlusion
p
No (n=920) Yes (n=88)
Age (years) 62.6±11.5 65.7±10.2 0.015
Men (%) 635 (69.2) 63 (71.6) 0.648
Hypertension (%) 399 (43.6) 46 (54.1) 0.062
Smoker (%) 579 (65.3) 52 (62.7) 0.631
Diabetes mellitus (%) 250 (27.4) 36 (41.9) 0.005
Hyperlipidemia (%) 265 (32.3) 18 (22.8) 0.081
Previous MI (%) 43 (4.7) 19 (21.6) <0.001
Ejection fraction 52.5±10.3 49.1±10.3 0.006
Killip class ≥III (%) 125 (14.6) 23 (27.4) 0.002
STEMI (%) 498 (54.2) 26 (29.5) <0.001
MI related to LAD (%) 384 (42.7) 35 (41.7) 0.853
MI: myocardial infarction, STEMI: ST-segment elevation MI, LAD: left ante-
rior descending artery
Single vessel disease
Multivessel disease98  Impact of Chronic Total Occlusion
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cant predictor of one-year mortality or cardiac death.
 
Discussion
The purpose of this study was to determine the impact of MVD 
with CTO on one-year mortality in patients with AMI. Results of the 
present study are in line with those of a previous study demon-
strating that patients with MVD had a higher one-year mortality 
than SVD patients. There were several differences in the baseline ch-
aracteristics between patients with and without MVD. Patients with 
MVD were older and had a more frequent history of diabetes, hyper-
tension or previous MI, and a lower LVEF than SVD patients. There-
fore, the mortality difference could be explained by a higher preval-
ence of associated risk factors in patients with MVD. 
In this study, CTO lesion was present in 8% of all study patients 
and in 20% of patients with MVD. CTO PCI was attempted in 60 
(68%) patients. Successful opening was obtained in 66% of the at-
tempted cases. Patients with CTO lesion were older, more often dia-
betic, and had more unfavorable Killip class compared with patients 
without that lesion. Of note, STEMI was more frequent in patients 
without CTO lesion. Among the 88 patients with CTO lesion, there 
were 11 deaths, all of which were of cardiac origin. We found that 
the presence of CTO was not a significant predictor of one-year ov-
erall mortality and cardiac mortality of AMI patients. These findings 
are in contrast to the results of van der Schaaf et al.
9) They insisted 
that the presence of a CTO, but not the mere presence of MVD, was 
an independent predictor of one-year mortality. Moreover, they also 
evaluated the effects of a concurrent CTO on long-term mortality 
and left ventricular function.
12) They found that the presence of CTO 
lesion, but not MVD alone, was associated with long-term mortality 
Table 4. Predictors of 12-month mortality
Predictor
Univariate analysis  Multivariate analysis
HR 95% CI p HR 95% CI p
All cause death
Age >65 3.42 2.08-5.65 <0.001 2.41 1.43-4.08 0.001
Male 0.496 0.32-0.77 0.002 0.68 0.42-1.07 0.096
Diabetes mellitus 1.324 0.83-2.11 0.238 1.05 0.65-1.71 0.835
Previous MI 1.037 0.42-2.57 0.938 1.35 0.53-3.44 0.526
Killip class ≥III 5.119 3.27-8.01 <0.000 3.59 2.24-5.77 <0.001
STEMI 2.154 1.33-3.48 0.002 2.45 1.49-4.05 <0.001
MVD 1.766 1.13-2.76 0.013 1.76 1.07-2.89 0.026
Presence of CTO 1.786 0.94-3.38 0.075 1.20 0.59-2.42 0.618
Cardiac death
Age >65 3.487 2.04-5.98 <0.000 2.50 1.42-4.39 0.001
Male 0.540 0.34-0.87 0.012 0.74 0.45-1.22 0.234
Diabetes mellitus 1.362 0.83-2.24 0.223 1.07 0.63-1.79 0.810
Previous MI 0.945 0.34-2.59 0.912 1.53 0.54-4.32 0.424
Killip class ≥III 5.261 3.26-8.50 <0.000 3.55 2.14-5.90 <0.001
STEMI 2.653 1.55-4.55 <0.000 3.16 1.81-5.53 <0.001
MVD 2.068 1.27-3.36 0.003 2.11 1.23-3.61 0.007
Presence of CTO 2.092 1.10-3.99 0.025 1.36 0.66-2.77 0.403
MI: myocardial infarction, MVD: multivessel disease, STEMI: ST-segment elevation MI, CTO: Chronic total occlusion, HR: hazard ratio, CI: confidence interval
Fig. 2. Twelve-month mortality according to presence of chronic total oc-
clusion.
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even when early deaths were excluded from the analysis, and the 
presence of CTO lesion was associated with reduced LVEF and fur-
ther deterioration of LVEF. Although the reason for these differenc-
es is not clear, the impact of successful revascularization of CTO 
might have affected the results. In our study, although the number 
of CTO was small, successful revascularization of CTO was obtained 
in more than 40% of patients with CTO lesion. It is also known that 
delayed opening of CTO has beneficial effects on long-term mor-
tality.
13-17) The difference in the study populations may be another 
explanation for the discrepancies in these results. We included not 
only STEMI, but also NSTEMI.
To the best of our knowledge, the present study is the first study 
to evaluate the impact of concurrent CTO that was revascularized 
on 12-month mortality in patients with AMI. A previous study re-
porting the impact of concurrent CTO on mortality in patients with 
AMI did not include the CTO lesions that were successfully revas-
cularized.
Limitations
Our study had several limitations. 
First, the number of patients, especially of patients with CTO, was 
small. Therefore, the statistical power to detect differences in mor-
tality between patients with or without CTO lesion was limited. Sec-
ond, this study was a retrospective study, not a randomized con-
trolled study. We could not investigate the benefit of opening the 
concurrent CTO lesion. Selection bias might have occurred in decid-
ing to attempt CTO revascularization. Third, there was a possibility 
of the inclusion of patients who had the occlusion for less than 3 
months. 
 
Conclusion
Patients with MVD have a higher one-year mortality than patients 
with SVD, which can be explained by a greater prevalence of asso-
ciated risk factors in patients with MVD. However, the presence of a 
CTO was not an independent predictor of one-year mortality in AMI 
patients after including successfully revascularized CTO lesions. A 
larger patient population in a randomized controlled trial is needed 
to assess the possible benefit of successful revascularization of con-
current CTO lesion.
References
1. O’ Keefe JH Jr, Rutherford BD, McConahay DR, et al. Early and late re-
sults of coronary angioplasty without antecedent thrombolytic thera-
py for acute myocardial infarction. Am J Cardiol 1989;64:1221-30.
2. Moreno R, García E, Soriano J, et al. Early coronary angioplasty for acu-
te myocardial infarction: predictors of poor outcome in a non-selected 
population. J Invasive Cardiol 2001;13:202-10.
3. van der Schaaf RJ, Timmer YR, Ottervanger JP, et al. Long-term impact 
of multivessel disease on cause-specific mortality after ST elevation 
myocardial infarction treated with reperfusion therapy. Heart 2006; 
92:1760-3.
4. De Boer MJ, Suryapranata H, Hoorntje JC, et al. Limitation of infarct 
size and preservation of left ventricular function after primary coro-
nary angioplasty compared with intravenous streptokinase in acute 
myocardial infarction. Circulation 1994;90:753-61.
5. Shihara M, Tsutsui H, Tsuchihashi M, Tada H, Kono S, Takeshita A; Ja-
panese Coronary Invention Study (JCIS) Group. In-hospital and one-
year outcomes for patients undergoing percutaneous coronary inter-
vention for acute myocardial infarction. Am J Cardiol 2002;90:932-6.
6. Parodi G, Memisha G, Valenti R, et al. Five year outcome after primary 
coronary intervention for acute ST elevation myocardial infarction: 
results from a single centre experience. Heart 2005;91:1541-4.
7. Waldecker B, Wass W, Haberbosch W, Voss R, Heizmann H, Tillmanns 
H. Long-term follow-up after direct percutaneous transluminal coro-
nary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 
32:1320-5.
8. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Ka-
padia SR. Effects of chronic total coronary occlusion on treatment st-
rategy. Am J Cardiol 2005;95:1088-91.
9. van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivessel 
coronary disease on long-term mortality in patients with ST-elevation 
myocardial infarction is due to the presence of a chronic total occlu-
sion. Am J Cardiol 2006;98:1165-9.
10. Claessen BE, Hoebers LP, van der Schaaf RJ, et al. Prevalence and im-
pact of a chronic total occlusion in a non-infarct-related artery on long- 
term mortality in diabetic patients with ST elevation myocardial in-
farction. Heart 2010;96:1968-72.
11. French JK, White HD. Clinical implications of the new definition of 
myocardial infarction. Heart 2004;90:99-106.
12. Claessen BE, van der Schaaf RJ, Verouden NJ, et al. Evaluation of the 
effect of a concurrent chronic total occlusion on long-term mortality 
and left ventricular function in patients after primary percutaneous 
coronary intervention. JACC Cardiovsc Interv 2009;2:1128-34.
13. Schömig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in 
patients with acute myocardial infarction presenting more than 12 
hours from symptom onset: a randomized controlled trial. JAMA 2005; 
293:2865-72.
14. Piscione F, Galasso G, De Luca G, et al. Late reopening of an occluded 
infarct related artery improves left ventricular function and long term 
clinical outcome. Heart 2005;91:646-51.
15. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-
term survival among patients undergoing percutaneous coronary in-
tervention of a chronic total occlusion in native coronary arteries: a 
20-year experience. J Am Coll Cardiol 2001;38:409-14.
16. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous 
coronary intervention for chronic total occlusions: the Thoraxcenter 
experience 1992-2002. Eur Heart J 2005;26:2630-6.
17. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic 
total occlusions: a systematic review and meta-analysis. Am Heart J 
2010;160:179-87. 